$GEN #Genmab A/S GENMAB: Highly anticipated Epcoritamab’s partnership signed with AbbVie | NEUTRAL | DKK2000 vs. DKK1950 (+2%): GENMAB - NEUTRAL | DKK2000 vs. DKK1950 (+2%) Highly anticipated Epcoritamab’s partnership signed with AbbVie… https://t.co/1DLFybZcUN #equity #stocks https://t.co/6E4rt0Dxij